Javara and Ogden Clinic have announced the launch of a partnership to integrate industry-sponsored clinical trials at the point of care for Ogden Clinic patients. Through this partnership, Javara will enable access to clinical trials for patients throughout the Ogden Clinic network by providing services to support and conduct research. The Ogden Clinic currently spans 20 locations in northern Utah and includes 171 practitioners across 24 specialties.
Javara will embed clinical research infrastructure and site staff, led by Javara’s Clinical Trial Navigators, who will work alongside the practitioners and medical staff to scale clinical trial operations. Javara and Ogden Clinic anticipate early clinical trials in general medicine, pediatrics, and dermatology, with initial trials expected to begin in 4th quarter of 2021.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Oveporexton Shows Superior Efficacy in Phase II Narcolepsy Type 1 Trial Without Hepatotoxicity
May 16th 2025In the TAK-861-2001 Phase IIb study, oveporexton significantly improved wakefulness, daytime sleepiness, and cataplexy frequency in patients with narcolepsy type 1, outperforming current therapies and avoiding liver toxicity seen with earlier OX2R agonists, according to results published in The New England Journal of Medicine.